Review Article
[Retracted] A Comprehensive Review on Metabolic Syndrome
Table 5
Goals for lowering LDL-C [
173].
| | Risk category | LDL-C goals | Recommendations |
| Lower risk
0-1 major risk factor
10-yr risk <10% | <160 mg/dL | Lifestyle modifications
Consider pharmacotherapy if LDL-C ≥190 mg/dL after lifestyle modifications |
| Moderate risk
≥2 major risk factors
10-yr risk <10% | <130 mg/dL | Lifestyle modifications
Consider pharmacotherapy if LDL-C ≥160 mg/dL after lifestyle modifications |
| Moderately high risk
≥2 major risk factors
10-yr risk 10–20% | <130 mg/dL
Optional <100 mg/dL | Lifestyle modifications
Consider pharmacotherapy if LDL-C ≥130 mg/dL or optionally ≥100 mg/dL after lifestyle modifications |
| High risk
CHD or CHD risk equivalents | <100 mg/dL
Optional <70 mg/dL | Lifestyle modifications
Consider pharmacotherapy if LDL-C ≥100 mg/dL or optionally ≥70 mg/dL after lifestyle modifications |
|
|
